Evaluation of differential representative values between Chinese hamster cells and human lymphocytes in mitomycin C-induced cytogenetic assays and caspase-3 activity

被引:9
作者
Liao, Pei-Hu [1 ,2 ,3 ]
Lin, Ruey-Hseng [1 ,2 ]
Yang, Ming-Ling [4 ]
Li, Yi-Ching [1 ,2 ]
Kuan, Yu-Hsiang [1 ,2 ]
机构
[1] Chung Shan Med Univ, Dept Pharmacol, Sch Med, Taichung 402, Taiwan
[2] Chung Shan Med Univ Hosp, Taichung 402, Taiwan
[3] Chung Shan Med Univ, Coll Med, Inst Med, Taichung 402, Taiwan
[4] Chung Shan Med Univ, Dept Anat, Sch Med, Taichung 402, Taiwan
关键词
CHO; V79; human lymphocytes; MN; SCE; CA; mitomycin C; caspase-3; SISTER-CHROMATID EXCHANGE; HOMOLOGOUS RECOMBINATION; CHROMOSOMAL-ABERRATIONS; APOPTOSIS; CANCER; OVARY; CARCINOGENS; POPULATION; MECHANISMS; EXPOSURE;
D O I
10.1177/0748233711409974
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Chinese hamster ovary (CHO) cells, its lung fibroblasts (V79), and human lymphocytes are routinely used in in vitro cytogenetic assays, which include micronuclei (MN), sister chromatid exchange (SCE), and chromosome aberration (CA) assays. Mitomycin C (MMC), a DNA cross-link alkylating agent, is both an anticancer medicine and a carcinogen. To study the differential representative values of cell types in MMC-treated cytogenetic assays and its upstream factor, cysteine aspartic acid-specific protease (caspase)-3. Among the chosen cell types, lymphocytes expressed the highest sensitivity in all three MMC-induced assays, whereas CHO and V79 showed varied sensitivity in different assays. In MN assay, the sensitivity of CHO is higher than or equal to V79; in SCE assay, the sensitivity of CHO is the same as V79; and in CA assay, the sensitivity of CHO is higher than V79. In-depth analysis of CA revealed that in chromatid breaks and dicentrics formation, lymphocyte was the most sensitive of all and CHO was more sensitive than V79; and in acentrics and interchanges formation, lymphocyte was much more sensitive than the others. Furthermore, we found caspase-3 activity plays an important role in MMC-induced cytogenetic assays, with MMC-induced caspase-3 activity resulting in more sensitivity in lymphocytes than in CHO and V79. Based on these findings, lymphocyte will make a suitable predictive or representative control reference in cytogenetic assays and caspase-3 activity with its high specificity, positive predictive value, and sensitivity.
引用
收藏
页码:174 / 180
页数:7
相关论文
共 32 条
[1]   Antitumor agents 4.: Characterization of free radicals produced during reduction of the antitumor drug 5H-pyridophenoxazin-5-one:: An EPR study [J].
Alberti, A ;
Bolognese, A ;
Guerra, M ;
Lavecchia, A ;
Macciantelli, D ;
Marcaccio, M ;
Novellino, E ;
Paolucci, F .
BIOCHEMISTRY, 2003, 42 (41) :11924-11931
[2]   IPCS guidelines for the monitoring of genotoxic effects of carcinogens in humans [J].
Albertini, RJ ;
Anderson, D ;
Douglas, GR ;
Hagmar, L ;
Hemminki, K ;
Merlo, F ;
Natarajan, AT ;
Norppa, H ;
Shuker, DEG ;
Tice, R ;
Waters, MD ;
Aitio, A .
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH, 2000, 463 (02) :111-172
[3]   Multiple roles of the tumor suppressor p53 [J].
Bargonetti, J ;
Manfredi, JJ .
CURRENT OPINION IN ONCOLOGY, 2002, 14 (01) :86-91
[4]   Mechanisms of caspase activation [J].
Boatright, KM ;
Salvesen, GS .
CURRENT OPINION IN CELL BIOLOGY, 2003, 15 (06) :725-731
[5]   Human population studies with cytogenetic biomarkers:: Review of the literature and future prospectives [J].
Bonassi, S ;
Ugolini, D ;
Kirsch-Volders, M ;
Strömberg, U ;
Vermeulen, R ;
Tucker, JD .
ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2005, 45 (2-3) :258-270
[6]   Chromosomal aberrations and risk of cancer in humans: an epidemiologic perspective [J].
Bonassi, S ;
Znaor, A ;
Norppa, H ;
Hagmar, L .
CYTOGENETIC AND GENOME RESEARCH, 2004, 104 (1-4) :376-382
[7]  
Bonassi S, 2000, CANCER RES, V60, P1619
[8]   CELLULAR STRESS BY LIGHT AND ROSE-BENGAL IN HUMAN-LYMPHOCYTES [J].
CARBALLO, M ;
ALVAREZ, S ;
BOVERIS, A .
MUTATION RESEARCH, 1993, 288 (02) :215-222
[9]   CONSIDERATIONS FOR POPULATION MONITORING USING CYTOGENETIC TECHNIQUES [J].
CARRANO, AV ;
NATARAJAN, AT .
MUTATION RESEARCH, 1988, 204 (03) :379-406
[10]  
CARTER SK, 1968, CANCER CHEMOTH REP 3, V1, P99